Medical Data Vision Co., Ltd.
3902.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | ¥5,906,958 | ¥6,419,026 | ¥6,104,599 | ¥5,672,300 |
| % Growth | -8% | 5.2% | 7.6% | – |
| Cost of Goods Sold | ¥1,575,573 | ¥1,388,024 | ¥1,074,564 | ¥1,028,541 |
| Gross Profit | ¥4,331,385 | ¥5,031,002 | ¥5,030,035 | ¥4,643,759 |
| % Margin | 73.3% | 78.4% | 82.4% | 81.9% |
| R&D Expenses | ¥290,000 | ¥68,000 | ¥332,985 | ¥316,638 |
| G&A Expenses | ¥3,529,000 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥4,037,000 | ¥3,191,906 | ¥2,938,996 | ¥2,732,902 |
| Sales & Mktg Exp. | ¥508,000 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥620 | ¥175 | ¥0 | ¥0 |
| Operating Expenses | ¥4,327,620 | ¥3,260,081 | ¥3,271,981 | ¥3,049,540 |
| Operating Income | ¥3,765 | ¥1,770,921 | ¥1,758,053 | ¥1,594,218 |
| % Margin | 0.1% | 27.6% | 28.8% | 28.1% |
| Other Income/Exp. Net | -¥731,073 | -¥202,999 | -¥331,470 | -¥2,322 |
| Pre-Tax Income | -¥727,308 | ¥1,567,922 | ¥1,426,583 | ¥1,591,896 |
| Tax Expense | ¥76,168 | ¥613,624 | ¥569,516 | ¥491,858 |
| Net Income | -¥791,170 | ¥979,125 | ¥870,509 | ¥1,087,267 |
| % Margin | -13.4% | 15.3% | 14.3% | 19.2% |
| EPS | -20.73 | 25.63 | 22.77 | 27.74 |
| % Growth | -180.9% | 12.6% | -17.9% | – |
| EPS Diluted | -20.73 | 25.63 | 22.76 | 27.74 |
| Weighted Avg Shares Out | 38,160 | 38,197 | 38,234 | 39,189 |
| Weighted Avg Shares Out Dil | 38,160 | 38,197 | 38,234 | 39,189 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥283 | ¥62 | ¥157 | ¥30 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥127,000 | ¥102,020 | ¥149,994 | ¥135,552 |
| EBITDA | ¥130,000 | ¥1,872,000 | ¥1,908,047 | ¥1,727,449 |
| % Margin | 2.2% | 29.2% | 31.3% | 30.5% |